OpenURL Connection Search

Select item for more details and to access through your institution.

Breast Conservation After Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: Surgical Results From the BrighTNess Randomized Clinical Trial.
Published in:
2020
By:
- Golshan, Mehra;
- Loibl, Sibylle;
- Wong, Stephanie M.;
- Houber, Jens Bodo;
- O'Shaughnessy, Joyce;
- Rugo, Hope S.;
- Wolmark, Norman;
- McKee, Mark D.;
- Maag, David;
- Sullivan, Danielle M.;
- Metzger-Filho, Otto;
- Von Minckwitz, Gunter;
- Geyer, Charles E.;
- Sikov, William M.;
- Untch, Michael;
- Geyer, Charles E Jr
Publication type:
journal article
Epirubicin With Cyclophosphamide Followed by Docetaxel With Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or as Adjuvant Therapy for HER2-Positive Pathologic Stage III Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group, FB-5.
Published in:
2017
By:
- Smith II, John W.;
- Buyse, Marc E.;
- Rastogi, Priya;
- Geyer Jr., Charles E.;
- Jacobs, Samuel A.;
- Patocskai, Erica J.;
- Robidoux, André;
- Conlin, Alison K.;
- Ansari, Bilal;
- Keogh, George P.;
- Stella, Philip J.;
- Gross, Howard M.;
- Lord, Raymond S.;
- Polikoff, Jonathan A.;
- Mauquoi, Celine;
- Mamounas, Eleftherios P.;
- Swain, Sandra M.;
- Wolmark, Norman;
- Smith, John W 2nd;
- Geyer, Charles E Jr
Publication type:
journal article
Validation of the NSABP/NRG Oncology 8-Gene Trastuzumab-benefit Signature in Alliance/NCCTG N9831.
Published in:
JNCI Cancer Spectrum, 2020, v. 4, n. 5, p. 1, doi. 10.1093/jncics/pkaa058
By:
- Pogue-Geile, Katherine L;
- Song, Nan;
- Serie, Daniel J;
- Wang, Ying;
- Gavin, Patrick G;
- Kim, Rim S;
- Tanaka, Noriko;
- Fumagalli, Debora;
- Taniyama, Yusuke;
- Li, Zhuo;
- Rastogi, Priya;
- Swain, Sandra M;
- Mamounas, Eleftherios P;
- Geyer, Charles E;
- Wolmark, Norman;
- Lucas, Peter C;
- Paik, Soonmyung;
- Thompson, E Aubrey
Publication type:
Article
Replication of genetic associations of chemotherapy-related cardiotoxicity in the adjuvant NSABP B-31 clinical trial.
Published in:
Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.1139347
By:
- Advani, Pooja P.;
- Ruddy, Kathryn J.;
- Herrmann, Joerg;
- Ray, Jordan C.;
- Craver, Emily C.;
- Yothers, Greg;
- Cecchini, Reena S.;
- Lipchik, Corey;
- Huichen Feng;
- Rastogi, Priya;
- Mamounas, Eleftherios P.;
- Swain, Sandra M.;
- E. Geyer Jr., Charles;
- Wolmark, Norman;
- Soonmyung Paik;
- Pogue-Geile, Katherine L.;
- Colon-Otero, Gerardo;
- Perez, Edith A.;
- Norton, Nadine
Publication type:
Article
Early and Locally Advanced Metaplastic Breast Cancer: Presentation and Survival by Receptor Status in Surveillance, Epidemiology, and End Results (SEER) 2010–2014.
Published in:
Oncologist, 2018, v. 23, n. 4, p. 481, doi. 10.1634/theoncologist.2017-0398
By:
- Schroeder, Mary C.;
- Rastogi, Priya;
- Geyer Jr., Charles E.;
- Miller, Lance D.;
- Thomas, Alexandra
Publication type:
Article
Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19).
Published in:
2020
By:
- McCullough, Peter A.;
- Alexander, Paul E.;
- Armstrong, Robin;
- Arvinte, Cristian;
- Bain, Alan F.;
- Bartlett, Richard P.;
- Berkowitz, Robert L.;
- Berry, Andrew C.;
- Borody, Thomas J.;
- Brewer, Joseph H.;
- Brufsky, Adam M.;
- Clarke, Teryn;
- Derwand, Roland;
- Eck, Alieta;
- Eck, John;
- Eisner, Richard A.;
- Fareed, George C.;
- Farella, Angelina;
- Fonseca, Silvia N. S.;
- Geyer Jr., Charles E.
Publication type:
journal article
Rare subtypes of triple negative breast cancer: Current understanding and future directions.
Published in:
NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00554-x
By:
- Thomas, Alexandra;
- Reis-Filho, Jorge S.;
- Geyer Jr, Charles E.;
- Wen, Hannah Y.
Publication type:
Article
Adjuvant trastuzumab emtansine in HER2-positive breast cancer patients with HER2-negative residual invasive disease in KATHERINE.
Published in:
NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00477-z
By:
- Loibl, Sibylle;
- Huang, Chiun-Sheng;
- Mano, Max S.;
- Mamounas, Eleftherios P.;
- Geyer Jr, Charles E.;
- Untch, Michael;
- Thery, Jean-Christophe;
- Schwaner, Ingo;
- Limentani, Steven;
- Loman, Niklas;
- Lübbe, Kristina;
- Chang, Jenny C.;
- Hatschek, Thomas;
- Tesarowski, David;
- Song, Chunyan;
- Lysbet de Haas, Sanne;
- Boulet, Thomas;
- Lambertini, Chiara;
- Wolmark, Norman
Publication type:
Article
Anthracyclines in the Treatment of HER2-Negative Breast Cancer.
Published in:
JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 1, p. 2, doi. 10.1093/jnci/djm277
By:
- Soonmyung Paik;
- Taniyama, Yusuke;
- Geyer Jr., Charles E.
Publication type:
Article
Concurrent Bevacizumab with a Sequential Regimen of Doxorubicin and Cyclophosphamide Followed by Docetaxel and Capecitabine as Neoadjuvant Therapy for HER2&strns; Locally Advanced Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group.
Published in:
Clinical Breast Cancer, 2011, v. 11, n. 4, p. 228, doi. 10.1016/j.clbc.2011.04.001
By:
- Rastogi, Priya;
- Buyse, Marc E.;
- Swain, Sandra M.;
- Jacobs, Samuel A.;
- Robidoux, André;
- Liepman, Marcia K.;
- Pajon, Eduardo R.;
- Dy, Philip A.;
- Posada, Jr, Juan G.;
- Melnik, Marianne K.;
- Piette, Fanny;
- Geyer, Jr, Charles E.;
- Mamounas, Elfetherios P.;
- Wolmark, Norman
Publication type:
Article
A Phase II Neoadjuvant Trial of Sequential Nanoparticle Albumin-Bound Paclitaxel Followed by 5-Fluorouracil/Epirubicin/Cyclophosphamide in Locally Advanced Breast Cancer.
Published in:
Clinical Breast Cancer, 2010, v. 10, n. 1, p. 81, doi. 10.3816/CBC.2010.n.011
By:
- Robidoux, André;
- Buzdar, Aman U.;
- Quinaux, Emmanuel;
- Jacobs, Samuel;
- Rastogi, Priya;
- Fourchotte, Virginie;
- Younan, Rami J.;
- Pajon, Eduardo R.;
- Shalaby, Ibrahim A.;
- Desai, Ajit M.;
- Fehrenbacher, Louis;
- Geyer, Jr., Charles E.;
- Mamounas, Eleftherios P.;
- Wolmark, Norman
Publication type:
Article
A multicenter, phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinoma.
Published in:
1999
By:
- Rothenberg, Mace L.;
- Cox, John V.;
- DeVore, Russell F.;
- Hainsworth, John D.;
- Pazdur, Richard;
- Rivkin, Saul E.;
- Macdonald, John S.;
- Geyer, Charles E.;
- Sandbach, John;
- Wolf, Daniel L.;
- Mohrland, J. Scott;
- Elfring, Gary L.;
- Miller, Langdon L.;
- Von Hoff, Daniel D.;
- Rothenberg, M L;
- Cox, J V;
- DeVore, R F;
- Hainsworth, J D;
- Pazdur, R;
- Rivkin, S E
Publication type:
journal article
Long-term outcomes of dual vs single HER2-directed neoadjuvant therapy in NSABP B-41.
Published in:
Breast Cancer Research & Treatment, 2023, v. 199, n. 2, p. 243, doi. 10.1007/s10549-023-06881-8
By:
- Rastogi, Priya;
- Tang, Gong;
- Hassan, Saima;
- Geyer Jr, Charles E.;
- Azar, Catherine A.;
- Magrinat, Gustav C.;
- Suga, J. Marie;
- Bear, Harry D.;
- Baez-Diaz, Luis;
- Sarwar, Shakir;
- Boileau, Jean-Francois;
- Brufsky, Adam M.;
- Shibata, Henry R.;
- Bandos, Hanna;
- Paik, Soonmyung;
- Yothers, Greg;
- Swain, Sandra M.;
- Mamounas, Eleftherios P.;
- Wolmark, Norman
Publication type:
Article
Correction to: Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology).
Published in:
2022
By:
- Geyer Jr., Charles E.;
- Bandos, Hanna;
- Rastogi, Priya;
- Jacobs, Samuel A.;
- Robidoux, André;
- Fehrenbacher, Louis;
- Ward, Patrick J.;
- Polikoff, Jonathan;
- Brufsky, Adam M.;
- Provencher, Louise;
- Paterson, Alexander H. G.;
- Hamm, John T.;
- Carolla, Robert L.;
- Baez-Diaz, Luis;
- Julian, Thomas B.;
- Swain, Sandra M.;
- Mamounas, Eleftherios P.;
- Wolmark, Norman
Publication type:
Correction Notice
Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology).
Published in:
Breast Cancer Research & Treatment, 2022, v. 193, n. 3, p. 555, doi. 10.1007/s10549-021-06417-y
By:
- Geyer Jr., Charles E.;
- Bandos, Hanna;
- Rastogi, Priya;
- Jacobs, Samuel A.;
- Robidoux, André;
- Fehrenbacher, Louis;
- Ward, Patrick J.;
- Polikoff, Jonathan;
- Brufsky, Adam M.;
- Provencher, Louise;
- Paterson, Alexander H. G.;
- Hamm, John T.;
- Carolla, Robert L.;
- Baez-Diaz, Luis;
- Julian, Thomas B.;
- Swain, Sandra M.;
- Mamounas, Eleftherios P.;
- Wolmark, Norman
Publication type:
Article
Behavioral and health outcomes from the NRG Oncology/NSABP B-36 trial comparing two different adjuvant therapy regimens for early-stage node-negative breast cancer.
Published in:
Breast Cancer Research & Treatment, 2022, v. 192, n. 1, p. 153, doi. 10.1007/s10549-021-06475-2
By:
- Ganz, Patricia A.;
- Bandos, Hanna;
- Geyer Jr., Charles E.;
- Robidoux, André;
- Paterson, Alexander H. G.;
- Polikoff, Jonathan;
- Baez-Diaz, Luis;
- Brufsky, Adam M.;
- Fehrenbacher, Louis;
- Parsons, Ann W.;
- Ward, Patrick J.;
- Provencher, Louise;
- Hamm, John T.;
- Stella, Philip J.;
- Carolla, Robert L.;
- Margolese, Richard G.;
- Shibata, Henry R.;
- Perez, Edith A.;
- Wolmark, Norman
Publication type:
Article
Pathologic complete response and outcomes by intrinsic subtypes in NSABP B-41, a randomized neoadjuvant trial of chemotherapy with trastuzumab, lapatinib, or the combination.
Published in:
Breast Cancer Research & Treatment, 2019, v. 178, n. 2, p. 389, doi. 10.1007/s10549-019-05398-3
By:
- Swain, Sandra M.;
- Tang, Gong;
- Lucas, Peter C.;
- Robidoux, André;
- Goerlitz, David;
- Harris, Brent T.;
- Bandos, Hanna;
- Geyer, Charles E.;
- Rastogi, Priya;
- Mamounas, Eleftherios P.;
- Wolmark, Norman
Publication type:
Article
NRG Oncology/NSABP B-47 menstrual history study: impact of adjuvant chemotherapy with and without trastuzumab.
Published in:
NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00264-2
By:
- Ganz, Patricia A.;
- Cecchini, Reena S.;
- Fehrenbacher, Louis;
- Geyer, Charles E.;
- Rastogi, Priya;
- Crown, John P.;
- Thirlwell, Michael P.;
- Ellison, David M.;
- Boileau, Jean-Francois;
- Flynn, Patrick J.;
- Jeong, Jong-Hyeon;
- Mamounas, Eleftherios P.;
- Wolmark, Norman
Publication type:
Article
21-Gene assay as predictor of chemotherapy benefit in HER2-negative breast cancer.
Published in:
NPJ Breast Cancer, 2018, v. 4, n. 1, p. N.PAG, doi. 10.1038/s41523-018-0090-6
By:
- Geyer, Charles E.;
- Tang, Gong;
- Mamounas, Eleftherios P.;
- Rastogi, Priya;
- Paik, Soonmyung;
- Shak, Steven;
- Baehner, Frederick L.;
- Crager, Michael;
- Wickerham, D. Lawrence;
- Costantino, Joseph P.;
- Wolmark, Norman
Publication type:
Article
Ten-year update: NRG Oncology/National Surgical Adjuvant Breast and Bowel Project B-42 randomized trial: extended letrozole therapy in early-stage breast cancer.
Published in:
JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 11, p. 1302, doi. 10.1093/jnci/djad078
By:
- Mamounas, Eleftherios P;
- Bandos, Hanna;
- Rastogi, Priya;
- Lembersky, Barry C;
- Jeong, Jong-Hyeon;
- Geyer, Charles E;
- Fehrenbacher, Louis;
- Chia, Stephen K;
- Brufsky, Adam M;
- Walshe, Janice M;
- Soori, Gamini S;
- Dakhil, Shaker R;
- Wade, James L;
- McCarron, Edward C;
- Swain, Sandra M;
- Wolmark, Norman
Publication type:
Article
Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial.
Published in:
2021
By:
- Albain, Kathy S;
- Gray, Robert J;
- Makower, Della F;
- Faghih, Amir;
- Hayes, Daniel F;
- Geyer, Charles E;
- Dees, Elizabeth C;
- Goetz, Matthew P;
- Olson, John A;
- Lively, Tracy;
- Badve, Sunil S;
- Saphner, Thomas J;
- Wagner, Lynne I;
- Whelan, Timothy J;
- Ellis, Matthew J;
- Wood, William C;
- Keane, Maccon M;
- Gomez, Henry L;
- Reddy, Pavan S;
- Goggins, Timothy F
Publication type:
journal article
Stromal Tumor-infiltrating Lymphocytes in NRG Oncology/NSABP B-31 Adjuvant Trial for Early-Stage HER2-Positive Breast Cancer.
Published in:
2019
By:
- Kim, Rim S;
- Song, Nan;
- Gavin, Patrick G;
- Salgado, Roberto;
- Bandos, Hanna;
- Kos, Zuzana;
- Floris, Giuseppe;
- Eynden, Gert G G M Van den;
- Badve, Sunil;
- Demaria, Sandra;
- Rastogi, Priya;
- Fehrenbacher, Louis;
- Mamounas, Eleftherios P;
- Swain, Sandra M;
- Wickerham, D Lawrence;
- Costantino, Joseph P;
- Paik, Soonmyung;
- Wolmark, Norman;
- Geyer, Charles E;
- Lucas, Peter C
Publication type:
journal article
T-DM1 Reduces Residual Invasive Disease in Patients with HER2-Positive Breast Cancer After Chemotherapy.
Published in:
Journal of Oncology Navigation & Survivorship, 2019, v. 10, n. 5, p. 186
By:
- Geyer, Charles E.
Publication type:
Article
Role of trastuzumab in the adjuvant treatment of HER2-positive early breast cancer.
Published in:
Women's Health (17455057), 2009, v. 5, n. 2, p. 135, doi. 10.2217/17455057.5.2.135
By:
- Haq, Bushra;
- Geyer, Charles E.
Publication type:
Article
Phase I and pharmacokinetic study of cisplatin and troxacitabine administered intravenously every 28 days in patients with advanced solid malignancies.
Published in:
Cancer Chemotherapy & Pharmacology, 2009, v. 65, n. 1, p. 167, doi. 10.1007/s00280-009-1020-y
By:
- Chia-Chi Lin;
- Beeram, Muralidhar;
- Rowinsky, Eric K.;
- Takimoto, Chris H.;
- Ng, Chee M.;
- Geyer Jr., Charles E.;
- Denis, Louis J.;
- De Bono, Johann S.;
- Hao, Desiree;
- Tolcher, Anthony W.;
- Rha, Sun-Young;
- Jolivet, Jacques;
- Patnaik, Amita
Publication type:
Article

Found: 25